“…In domestic animals, EGFR immunostaining has been reported in canine breast tumors (GAMA et al, 2009), primary brain tumors (LIU et al, 2001), nasal carcinomas (SHIOMITSU et al, 2009), lung carcinomas (SABATTINI et al, 2014, and gastric tumors (TERRAGNI et al, 2014). Likewise, cases of Her2 overexpression were reported in 19-35% of canine mammary tumors (HSU et al, 2009;RESSEL et al, 2013), and in 57.9% of canine gastric neoplasms (TERRAGNI et al, 2014).…”